◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksA › ACB

Aurora Cannabis Inc. (ACB) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-10

Aurora Cannabis Inc. (ACB) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Edmonton, Canada with about 1,028 employees. Its market capitalization is roughly $246 million. In the fiscal year ended 2026-03-31, ACB reported C$321M in revenue and (C$136M) in net income.

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.

Interactive charts & full statements → Open the ACB valuation workbench →

ACB Revenue & Earnings History — Annual Income Statement

Income statement2026-03-312025-03-312024-03-312022-06-30
Total RevenueC$321MC$289MC$270MC$221M
Gross ProfitC$137MC$181MC$132MC$21M
Operating Income (EBIT)(C$47M)C$10M(C$31M)(C$219M)
Net Income(C$136M)C$2M(C$69M)(C$1.7B)

CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ACB Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total RevenueC$68MC$38MC$94MC$90MC$74M
Gross ProfitC$36MC$30MC$47MC$32MC$34M
Operating Income (EBIT)(C$9M)(C$10M)C$2M(C$18M)(C$12M)
Net Income(C$4M)(C$71M)C$2M(C$52M)(C$20M)

CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ACB Free Cash Flow History

ACB Balance Sheet History

Balance sheet2026-03-312025-03-312024-03-312022-06-30
Total AssetsC$601MC$853MC$839MC$1.1B
Total LiabilitiesC$89MC$244MC$237MC$422M

CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ACB viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

← ACANAll “A” companiesACC →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.